FDA approved Kybella, deoxycholic acid, for treatment for submental fat
The U.S. Food and Drug Administration today approved Kybella (deoxycholic acid), a treatment for adults with moderate-to-severe fat below the chin, known... Read More
What is the difference between Verification and validation?
Posted on25 Apr 2015
Comments0
Verification and validation is done to make sure that the data is accurate and error free as the incorrect data can lead... Read More
FDA approves first generic Copaxone to treat multiple sclerosis
The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with... Read More
FDA approves first-of-its-kind corneal implant
The U.S. Food and Drug Administration today approved the KAMRA inlay, a device implanted in the cornea of one eye (the clear,... Read More
10 New Molecular Entity approved by USFDA in 2015 till date
As on that 10 new molecular entity is approved by USFDA. No. Drug Active Ingredient FDA-approved use on approval date 10 Cholbam... Read More
Teva Pharmaceutical offers to buy Mylan for $40.1 bn
Posted on22 Apr 2015
Comments0
Israel’s Teva Pharmaceutical Tuesday launched an unsolicited bid to buy Mylan for $40.1 billion in a transaction that would create a behemoth... Read More
Daiichi to exit Sun Pharma
Japanese drugmaker Daiichi Sankyo is close to exiting India, ending a bitter 7-year run that saw it face regulatory challenges in several... Read More
Sun Pharma Teams Up with Israel’s Technion to Develop New Cancer Drugs
Posted on20 Apr 2015
Comments0
Sun Pharmaceutical Industries and the Technion – Israel Institute of Technology announced that their respective subsidiaries have entered into an exclusive worldwide... Read More
Case Study – Ibrance – Next 5 Billion Potential
Posted on16 Apr 2015
Comments0
Palbociclib (codenamed PD-0332991, trade name Ibrance) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is... Read More
Immunocore and MedImmune Announce Collaboration Deal
Posted on16 Apr 2015
Comments0
Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases, and MedImmune, the global biologics research... Read More